HPV prevalence and HPV-related dysplasia in elderly women
- PMID: 29320507
- PMCID: PMC5761845
- DOI: 10.1371/journal.pone.0189300
HPV prevalence and HPV-related dysplasia in elderly women
Abstract
Introduction: In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cases occur in women older than 60. The aim of the present study was to investigate the prevalence of HPV and cervical dysplasia in women of 60 years and above.
Patients and methods: From September 2013 until June 2015, 1051 women aged 60-89 years (mean 68 years) were sampled for an HPV test when attending an outpatient gynecology clinic. Women with positive results had a second HPV test and liquid based cytology (LBC), after 3.5 months on average. Those with a positive second HPV test were examined by colposcopy, and biopsy and a sample for LBC was obtained.
Results: The prevalence of HPV was 4.1%, (95%CI 3.0-5.5, n = 43) at the first test, and at the second test 2.6% remained positive (95%CI 1.7-3.8, n = 27). The majority of women positive in both HPV tests, had dysplasia in histology, 81.5% (22/27) (4 CIN 2-0.4%, 18 CIN 1-1.7%). HPV-related dysplasia was found in 2.1%, (95%CI 1.3-3.2, n = 22) of the 1051 women. Four of the 22 women with positive HPV tests also had abnormal cytology, one ASCUS and three CIN 1. No cancer or glandular dysplasia was detected.
Conclusion: A significant proportion of elderly women were found to have a persistent cervical HPV infection. Among them there was a high prevalence of CIN diagnosed by histology. The HPV test showed high sensitivity and specificity in detecting CIN in elderly women, while cytology showed extremely low sensitivity.
Conflict of interest statement
Figures





Similar articles
-
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9. J Natl Cancer Inst. 2009. PMID: 19903804 Clinical Trial.
-
The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology.J Med Virol. 2020 Mar;92(3):364-371. doi: 10.1002/jmv.25611. Epub 2019 Nov 18. J Med Virol. 2020. PMID: 31642536
-
[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 16635326 Chinese.
-
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72. Epidemiol Prev. 2012. PMID: 22828243 Italian.
-
[Detection and quantification of human papillomavirus genital infections: virological, epidemiological, and clinical applications].Med Mal Infect. 2011 Feb;41(2):68-79. doi: 10.1016/j.medmal.2010.07.013. Epub 2010 Sep 15. Med Mal Infect. 2011. PMID: 20828954 Review. French.
Cited by
-
High Human Papillomavirus DNA loads in Inflammatory Middle Ear Diseases.Pathogens. 2020 Mar 18;9(3):224. doi: 10.3390/pathogens9030224. Pathogens. 2020. PMID: 32197385 Free PMC article.
-
A cervical screening initiative for elderly women in Denmark.Acta Obstet Gynecol Scand. 2023 Jun;102(6):791-800. doi: 10.1111/aogs.14574. Epub 2023 Apr 27. Acta Obstet Gynecol Scand. 2023. PMID: 37113048 Free PMC article.
-
Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study.Cancer Commun (Lond). 2022 Mar;42(3):191-204. doi: 10.1002/cac2.12256. Epub 2022 Feb 10. Cancer Commun (Lond). 2022. PMID: 35142100 Free PMC article.
-
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.Viruses. 2018 Dec 19;10(12):729. doi: 10.3390/v10120729. Viruses. 2018. PMID: 30572620 Free PMC article. Review.
-
The Distribution and Prevalence of High-Risk HPV Genotypes Other than HPV-16 and HPV-18 among Women Attending Gynecologists' Offices in Kazakhstan.Biology (Basel). 2021 Aug 18;10(8):794. doi: 10.3390/biology10080794. Biology (Basel). 2021. PMID: 34440026 Free PMC article.
References
-
- Bergstrom R, Sparen P, Adami HO (1999) Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 81: 159–166. doi: 10.1038/sj.bjc.6690666 - DOI - PMC - PubMed
-
- Socialstyrelsen (2015) Screening för livmoderhalscancer Rekommendation och behandlingsunderlag Sweden: Socialstyrelsen;2015 1–38. www.socialstyrelsen.se.juni2015.
-
- The Board of Health and Welfare CfE (2015.) Cancer incidence in Sweden 2014. www.sos.se.
-
- The Board of Health and Welfare CfE (2015) Causes of Death 2013. www.sos.se. pp. 277.
-
- Socialstyrelsen (2011) Dödsorsaker 2009.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical